Finally, we investigate XBP1s expression in over 170 breast cancer patients' samples, and show that XBP1s expression is highly correlated with overall survival in ER+ breast cancer patients, strongly suggesting a potential therapeutic application of XBP1 inhibitors in breast cancer treatment. This evidence concerns the gene XBP1 and breast carcinoma.